company background image
EYE

Nova Eye Medical ASX:EYE Stock Report

Last Price

AU$0.23

Market Cap

AU$32.8m

7D

-10.0%

1Y

-43.0%

Updated

24 Sep, 2022

Data

Company Financials +
EYE fundamental analysis
Snowflake Score
Valuation3/6
Future Growth1/6
Past Performance0/6
Financial Health5/6
Dividends0/6

EYE Stock Overview

Nova Eye Medical Limited designs, develops, distributes, markets, sells, and services surgical devices for the treatment of glaucoma.

Nova Eye Medical Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Nova Eye Medical
Historical stock prices
Current Share PriceAU$0.23
52 Week HighAU$0.42
52 Week LowAU$0.18
Beta0.78
1 Month Change-10.00%
3 Month Change18.42%
1 Year Change-43.04%
3 Year Change-60.53%
5 Year Change-79.36%
Change since IPO-62.05%

Recent News & Updates

Aug 27
We Think Nova Eye Medical (ASX:EYE) Needs To Drive Business Growth Carefully

We Think Nova Eye Medical (ASX:EYE) Needs To Drive Business Growth Carefully

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Shareholder Returns

EYEAU Medical EquipmentAU Market
7D-10.0%-6.6%-2.7%
1Y-43.0%-22.7%-11.0%

Return vs Industry: EYE underperformed the Australian Medical Equipment industry which returned -22.7% over the past year.

Return vs Market: EYE underperformed the Australian Market which returned -11% over the past year.

Price Volatility

Is EYE's price volatile compared to industry and market?
EYE volatility
EYE Average Weekly Movement11.2%
Medical Equipment Industry Average Movement11.4%
Market Average Movement9.6%
10% most volatile stocks in AU Market16.9%
10% least volatile stocks in AU Market4.3%

Stable Share Price: EYE is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 11% a week.

Volatility Over Time: EYE's weekly volatility (11%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1985n/aTom Spurlinghttps://nova-eye.com

Nova Eye Medical Limited designs, develops, distributes, markets, sells, and services surgical devices for the treatment of glaucoma. The company offers iTrack, a surgical system for the reduction in intraocular pressure (IOP) in adult patients with open-angle glaucoma; iTrack Advance, a natural ocular drainage system; Molteno3, a glaucoma drainage device to treat patients with severe or complex glaucoma; and 2RT, a proprietary laser technology to treat patients in early/intermediate age-related macular degeneration. It operates in Australia, the United States, Europe, the Asia Pacific, and internationally.

Nova Eye Medical Limited Fundamentals Summary

How do Nova Eye Medical's earnings and revenue compare to its market cap?
EYE fundamental statistics
Market CapAU$32.82m
Earnings (TTM)-AU$7.50m
Revenue (TTM)AU$13.38m

2.5x

P/S Ratio

-4.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
EYE income statement (TTM)
RevenueAU$13.38m
Cost of RevenueAU$2.29m
Gross ProfitAU$11.09m
Other ExpensesAU$18.59m
Earnings-AU$7.50m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.051
Gross Margin82.89%
Net Profit Margin-56.03%
Debt/Equity Ratio0%

How did EYE perform over the long term?

See historical performance and comparison